Cellectis Adr Representing Sa
Cellectis S.A., a clinical‑stage biopharma in Paris, focuses on gene‑edited allogeneic CAR‑T therapies for hematologic cancers, advancing candidates such as ALLO‑501 and UCART123, positioning it as a high‑growth immuno‑oncology player.
Headquarters: France (FRA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 216
- HQ: Paris
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.